why is there a semaglutide shortage Hims & Hers stock falls 25% as FDA curtails compounded GLP-1s FDA Declares Shortage of Novo

However, these peptides are largely misunderstood and poorly discussed in todays hyper-wellness space

For example, some health insurance plans will only cover Wegovy as a cardiovascular risk treatment, not as a weight loss drug

[1] [3] According to the UK SmPC, dosing starts at 2.5 mg once weekly for 4 weeks, then increases in 2.5 mg increments every 4 weeks until the target dose (5 mg, 7.5 mg, 10 mg, 12.5 mg or 15 mg) is reached, based on individual response and tolerability

Discussion According to this meta-analysis, AOMs resulted in significant weight loss while being used, followed by weight regain after treatment discontinuation